0001517026-21-000009.txt : 20211012 0001517026-21-000009.hdr.sgml : 20211012 20211012165555 ACCESSION NUMBER: 0001517026-21-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211009 FILED AS OF DATE: 20211012 DATE AS OF CHANGE: 20211012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Verratti Mark CENTRAL INDEX KEY: 0001517026 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 211319167 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SATL LAKE CITY STATE: UT ZIP: 84003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: 801-584-3600 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-10-09 0 0000899923 MYRIAD GENETICS INC MYGN 0001517026 Verratti Mark 320 WAKARA WAY SALT LAKE CITY UT 84108 0 1 0 0 President, Myriad Neuroscience Common Stock 2021-10-09 4 F 0 3349 30.88 D 199010 D Common Stock 2021-10-09 4 F 0 4991 30.88 D 194019 D Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021. Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock October 8, 2021. By: Nathan A. Smith For: Mark Verratti 2021-10-12